Blue Biopharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-12-2024
- Paid Up Capital ₹ 0.50 M
as on 12-12-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -17.51%
(FY 2022)
- Profit -16.67%
(FY 2022)
- Ebitda 17.49%
(FY 2022)
- Net Worth 0.80%
(FY 2022)
- Total Assets 4.16%
(FY 2022)
About Blue Biopharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Chitguppa Ramakanth, Anil Madrahalli, and Jagdishraj Mahajan serve as directors at the Company.
- CIN/LLPIN
U74110TG2010PLC070262
- Company No.
070262
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2010
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Blue Biopharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdishraj Mahajan  | Director | 17-Sep-2018 | Current |
| Anil Madrahalli | Director | 29-Nov-2021 | Current |
| Chitguppa Ramakanth | Director | 29-Nov-2021 | Current |
Financial Performance and Corporate Structure Insights of Blue Biopharma.
Blue Biopharma Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 17.51% decrease. The company also saw a substantial fall in profitability, with a 16.67% decrease in profit. The company's net worth moved up by a moderate rise of 0.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blue Biopharma?
In 2022, Blue Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blue Biopharma?
Unlock and access historical data on people associated with Blue Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blue Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
